DEVELOPING UPPER LIMB MOTOR BIOMARKERS OF DEMENTIA
With
Kaylee Rudd,
Junior Research Fellow,
Wicking Dementia Research and Education Centre
University of Tasmania, Hobart, Tasmania
RESEARCHER PROFILE
Filmed in Hobart, Tasmania, Australia | February 2026
Kaylee is currently a research fellow with the Wicking Dementia Research and Education Centre at the University of Tasmania. She has recently submitted her PhD thesis, reporting the findings of her research on developing upper limb motor biomarkers of dementia. She has postgrad degrees in physiotherapy and experience working in the community and aged care across Tasmania for several years, where she worked with people with dementia.
Her experience underlined the importance of detecting cognitive impairment early and prompted her to join the Wicking to research dementia in 2021. Her research aims to better understand how movement is associated with cognition and to identify potential hand motor tests to help detect those at risk of developing cognitive impairment early.
One of the main highlights of her research experience has been close and regular collaboration with participants and team members of the ISLAND Clinic and the Tasmanian ISLAND Project.
Currently she coordinates the TapTalk project, a multi-level RHHRF funded project, which aims to develop a non-invasive screening test to detect risk of Alzheimer’s disease pathology.
Kaylee also contributes to national and international research projects. Examples are her work with the multisite Australian Dementia Network (ADNeT) study investigating the impact of blood-based biomarkers knowledge on clinician’s diagnostic confidence, and her ongoing collaboration with the AI-assisted motor biomarkers team in the University of Leeds, UK.
Collaborations and funding from
- Wicking Dementia research and Education Centre, University of Tasmania
- Royal Hobart Hospital, Tasmanian Health Service
- Royal Hobart Hospital Research Foundation (RHHRF)
Source: Supplied and adapted
https://orcid.org/0000-0002-8073-8691
-
Genomics and rationally targeted therapies in Acute Lymphoblastic Leukaemia
Prof Deborah White’s research focus is genomics and rationally targeted therapies in Acute Lymphoblastic Leukaemia (ALL) and Chronic Myeloid Leukaemia (CML) and she holds peer reviewed grants from: The William Lawrence and Blanche Hughes Foundation and the Leukemia Lymphoma Society (USA), the NHMRC, the Leukaemia Foundation Australia (LFA), Channel 7, Cancer Australia, Tour de Cure and the Cancer Council SA (CCSA). Professor White has presented more than 170 papers at scientific meetings, and authored more than 100 scientific publications as well as being an inventor on several international patents.
-
Dr Venkata Tarigoppula
RESEARCH IN BRAIN COMPUTER INTERFACE
@ SYNCHRON
MELBOURNE, VICTORIA, AUSTRALIA -
Novel therapies & next-gen medical devices in cardiovascular & vascular disease management
Professor Shirley Jansen AM is a distinguished vascular and endovascular surgeon whose career spans clinical leadership, academic excellence, and pioneering research. She currently holds the Lawrence-Brown Chair of Vascular Surgery at Curtin University’s School of Population Health and serves as Head of the Department of Vascular Surgery at Sir Charles Gairdner Hospital, a role she has held since 2015. In addition, she is the Director of the Heart & Vascular Research Institute at the Harry Perkins Institute for Medical Research. Her early career was marked by prestigious fellowships, including a British Heart Foundation Research Fellowship (1996), and multiple international travelling fellowships from leading surgical societies and industry sponsors between 2001 and 2002.
